Quantum-Si incorporated

NASDAQ:QSI

Biotechnology

Healthcare
$1.01 +5.02%

+$0.05 today

Market cap
$201.80M
Beta
3.17
P/E (TTM)
-2.1
EPS (TTM)
-$0.48
52W Low $0.69High $3.10

Volume 5.35M

Average 5.64M

QSI Interest Expense

Cost of servicing the company's debt during the period.

Quantum-Si incorporatedNASDAQ: QSI

Interest Expense · Q1 FY2026 · quarter ended Mar 2026

Interest expense remains negative

Q1 FY2026 interest expense was $0, compared with $0 a year earlier. Trailing-twelve-month interest expense was $0.

Context

  • Interest expense amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
  • Interest expense increased in 0 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly interest expense holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$0— QoQ
Last fiscal yearDec 2025
$0— YoY
LTMMar 2026
$0— YoY
Interest Expense past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Interest Expense history

USD · from the income statement

Latest · FY2025
0 USD
Year-over-year change
—

Interest Expense vs competitors

How QSI compares with its peers on the latest reported figures

  • QSI's LTM Mar 2026 interest expense of $0 is the 8th highest of the 11 companies compared; the peer median is $1.68M.
  • Interest expense amounts to 0.0% of revenue for QSI, versus a peer median of 65.4%.
QSI Competitors Peer median
Interest Expense for QSI and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ADCTADC Therapeutics S.A.LTM Mar 2026$51.75M +3.6%+12.0%65.4%
AUTLAutolus Therapeutics plcLTM Mar 2026$44.43M +26345.5%+60.4%48.0%
RCKTRocket Pharmaceuticals, Inc.LTM Mar 2026$4.73M +150.6%-0.3%—
ENGNenGene Holdings Inc.LTM Apr 2026$2.99M -0.3%+28.1%—
ALTAltimmune, Inc.LTM Mar 2026$2.7M +29933.3%+489.2%7508.3%
DBVTDBV Technologies S.A.LTM Mar 2026$656.17K +480.7%——
SLDBSolid Biosciences Inc.LTM Mar 2026$60K -80.8%——
QSIQuantum-Si incorporatedLTM Mar 2026$0 ——0.0%
AURAAura Biosciences, Inc.LTM Mar 2026$0 ———
ANNXAnnexon, Inc.LTM Mar 2026$0 ———
LBRXLB Pharmaceuticals Inc Common StockLTM Mar 2026-$206.5K ———
Peer median (excluding QSI) $1.68M+150.6%+28.1%65.4%

Competitors are the stored peer set for QSI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue001.08M3.06M2.44M
Cost of Revenue00594K1.46M1.28M
Gross Profit00488K1.6M1.15M
Gross Margin——45.1%52.3%47.3%
Research & Development46.58M72.06M67.03M59.64M53.76M
Selling, General & Admin50.33M42.3M44.63M50.54M44.75M
Operating Expenses96.91M123.84M111.66M110.18M98.51M
Depreciation & Amortization1.04M2.58M4.16M4.6M4.45M
EBITDA(93.94M)(111.77M)(91.8M)(96.35M)(96.83M)
EBITDA Margin——-8484.7%-3150.8%-3974.8%
Operating Income(96.91M)(123.84M)(111.17M)(108.58M)(97.36M)
Operating Margin——-10274.6%-3550.6%-3996.7%
Interest Income00008.96M
Interest Expense5K0000
Other Income / Expenses1.92M(8.6M)15.21M7.63M(3.92M)
Income Before Tax(94.99M)(132.44M)(95.96M)(100.95M)(101.28M)
Pre-Tax Margin——-8868.8%-3301.2%-4157.7%
Income Tax Expense00056K58K
Net Income(94.99M)(132.44M)(95.96M)(101.01M)(101.34M)
Net Margin——-8868.8%-3303.0%-4160.1%
EPS (Basic)(1.19)(0.95)(0.68)(0.71)(0.51)
EPS (Diluted)(1.19)(0.95)(0.68)(0.71)(0.51)
Weighted Avg Shares79.58M139.26M141.3M143.2M197.77M
Weighted Avg Shares (Diluted)79.58M139.26M141.3M143.2M197.77M

Quantum-Si incorporated

NASDAQ:QSI

Intrinsic Alpha fair value

Locked

Current Price

$1.01

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.